A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
about
2-D structure of the A region of Xist RNA and its implication for PRC2 associationDual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent changeThe hnRNPs F and H2 bind to similar sequences to influence gene expressionDiaspora, a large family of Ty3-gypsy retrotransposons in Glycine max, is an envelope-less member of an endogenous plant retrovirus lineageDepletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.Isolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognitionDifferential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNAAnalysis of sequence and structural features that identify the B/C motif of U3 small nucleolar RNA as the recognition site for the Snu13p-Rrp9p protein pairSmall-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistanceHuman neuronal cell protein responses to Nipah virus infection.Alternative splicing regulation during C. elegans development: splicing factors as regulated targets.Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila.Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.Transcriptional and posttranscriptional regulation of HIV-1 gene expressionGenomic HEXploring allows landscaping of novel potential splicing regulatory elements.Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.A novel function for Sam68: enhancement of HIV-1 RNA 3' end processing.Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expressionThe retrovirus RNA trafficking granule: from birth to maturity.NMR structure of the three quasi RNA recognition motifs (qRRMs) of human hnRNP F and interaction studies with Bcl-x G-tract RNA: a novel mode of RNA recognition.Proteomic analysis of anti-tumor effects of 11-dehydrosinulariolide on CAL-27 cells.The strength of the HIV-1 3' splice sites affects Rev function.Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replicationAn intronic element contributes to splicing repression in spinal muscular atrophy.Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2.Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteinsPosition-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms.HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages.Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNAA G-tract element in apoptotic agents-induced alternative splicing.tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.RNA processing control in avian retroviruseshnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndromeSuppression of HIV-1 replication by microRNA effectorsExtensive purifying selection acting on synonymous sites in HIV-1 Group M sequences.A computational approach for genome-wide mapping of splicing factor binding sites.
P2860
Q21145807-4683AD23-0A63-4D9B-99C4-D3F59ACE7603Q21245209-3D7CD005-3461-4561-A69C-85492B9B181AQ21262997-3E025EC6-173D-4247-A80D-51EAD48750F3Q24541421-6B6E0FE6-1121-437A-9D5B-399A196FA5E3Q24810172-BC90084A-1A8F-4052-88B7-AE21CE38E37FQ24811044-CF43DDD2-8D58-4878-9C4D-3BB5C5F498B5Q27678986-62EBEF87-A9AF-4A38-A68A-9332884A67D1Q28259926-B73D9890-2266-4229-BFCE-7B6D53ED3A9CQ28277193-CE69D29E-F69F-47DB-80A7-AA055172ADE4Q28469343-BB46FAB6-AC17-4CC8-AB98-9C5FF4092A57Q33286955-683F97C8-144B-431B-B23E-F78F5296E9B7Q33331560-8CEAF92B-8DFF-4628-B19B-7E94E817D8E2Q33649436-7DE3B25E-6BD9-4A83-867B-9C0EC3A1FE7CQ33841762-96B3F663-F22A-401E-979B-2A2AE45D14C4Q33853846-37AAA715-43F5-444C-B49D-85E8582A25F1Q33974928-A1AF258B-AC58-4BB4-A4CB-A2F51589397CQ34030804-AA458A38-D91E-46BB-ADA7-ED5E30F701D2Q34249488-8822E3D8-3982-4B9B-9085-EAF82B6D5DEAQ34351941-43CF0775-792D-4A6C-991C-A23755673A34Q34365863-E90E7FDC-37A5-4009-AEBD-23292E6C1052Q34546893-0243BA0C-AAC7-4999-8182-EF5EF0E42FAEQ34667412-459496B7-8FCC-4E49-9649-DF0AFFF181DEQ34977477-21F13DB7-E2E7-4E35-AFCC-52C7EFC4ED60Q35142085-072F21AF-E887-4D9D-9A73-8C7CB015C56AQ35220043-B57E527F-C3B2-4F91-A242-5C43E3B97AA3Q35575811-A68879FD-1BDA-4EBA-A3A3-04B6CDC7434EQ35652570-67FF36C7-F626-4BBA-B0EB-8D79AEFD3FA6Q35691190-1A923A65-81FD-4310-AD77-C6D508CCC97BQ36479939-23298C28-A499-47DB-9FA8-EC73847DC308Q36481243-234FC0C9-2515-4D3E-9CFC-CB40BE9F4249Q36496484-D14074BE-E559-4130-9907-99DA10C04543Q36540041-4B6813FD-8D7E-4493-A883-1F47D7D5787BQ36607087-348E27F3-BB0E-4E4F-815C-F147718A6223Q36715591-5DD9E784-6A2D-4264-B3F2-48C70B651D24Q36827396-3EC2E5B3-D896-446B-BABD-1B30A9AC98A8Q36955546-C2337AE0-3FAE-4A1B-8851-870AB7B7EC54Q37089623-51C0AF81-D046-438B-8CC4-28E705B6987DQ37133970-03B5B545-B23B-4256-ADF6-EB842B53D735Q37152994-DBFAE3C6-D4C6-4CFD-8B32-1C10919AAF10Q37213798-981927E2-D167-4A55-B4B7-92336B16F379
P2860
A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@ast
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@en
type
label
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@ast
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@en
prefLabel
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@ast
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@en
P2093
P2860
P356
P1476
A second exon splicing silence ...... RNA and binds protein hnRNP H.
@en
P2093
Bilodeau PS
Branlant C
Jacquenet S
Stoltzfus CM
P2860
P304
40464-40475
P356
10.1074/JBC.M104070200
P407
P577
2001-08-28T00:00:00Z